Where next for the Bubs Australia Ltd share price?

The Bubs Australia Ltd (ASX:BUB) share price has been on a rollercoaster ride recently. Where is it going next?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Last week certainly was an eventful week for the Bubs Australia Ltd (ASX: BUB) share price.

At one stage the shares of the infant formula and baby food company looked set to break through the $1.00 mark for the first time when they reached an all-time high of 96 cents.

But the next day its shares tumbled all the way down to as low as 61 cents. From top to bottom that's a staggering decline of over 36% and came after takeover speculation was dismissed by the company.

At present its shares are trading at 70 cents again. Which means that despite this sudden fall from grace, its shares are still up well over 400% in just the last three months.

Where next for the Bubs share price?

That certainly is the million dollar question.

With approximately 238 million shares outstanding, Bubs has a market cap of $166 million at the current share price.

Fourth-quarter revenue came in a $1.4 million, meaning annualised revenue is approximately $5.6 million at present.

This means its shares are changing hands at close to 30x annualised sales, compared to a2 Milk Company Ltd (Australia) (ASX: A2M) which trades at 7.4x sales.

While this immediately strikes me as overvalued, it is worth remembering that the company has yet to see the real benefits of its numerous supply agreements in the Chinese market.

If the company's deals do result in a significant lift in sales in FY 2018 as many in the market expect, then it could start to trade on a more reasonable sales multiple in the near future.

This could support the current share price or even take it higher. But it is of course a reasonably big "if" and makes an investment in Bubs a high risk one.

I would suggest that investors keep the company on their watchlist for the time being and look out for next quarter's sales result.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned.  The Motley Fool Australia owns shares of A2 Milk.We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »